Published Sep 13, 2021

175 - The biology of aging, rapamycin, and other interventions that target the aging process

Explore the cutting-edge of aging research as Peter Attia and Matt Kaeberlein delve into canine aging studies, the role of inflammation and mTOR in longevity, and the promising effects of rapamycin, while addressing regulatory hurdles and the quest for reliable biomarkers.
Episode Highlights
The Peter Attia Drive Podcast logo

Popular Clips

Episode Highlights